FindTrial
Sign In

COMPARING THE EFFECT OF TWO DRUGS CARBETOCIN AND OXYTOCIN IN THE PREVENTION OF POSTPARTUM HEMORRHAGE IN PRIMIGRAVIDA

A DOUBLE BLINDED RANDOMISED CONTROLLED TRIAL COMPARING EFFICACY OF CARBETOCIN VERSUS OXYTOCIN FOR THE PREVENTION OF POST PARTUM HEMORRHAGE IN LOW RISK PRIMIGRAVIDA

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051274
Enrollment
75
Registered
2023-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: A double blinded randomised controlled trialcomparing the efficacy of carbetocin versus oxytocin for the prevention of postpartum hemorrhage in low risk primigravida: All low risk primi

Sponsors

SDM COLLEGE MEDICAL SCIENCE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ALL PRIMIGRAVIDA WITH VAGINAL DELIVERY WITH NO COMBRIDITES

Exclusion criteria

Exclusion criteria: 1.MULTIPLE PREGNANCIES 2.MULTIGRAVIDA 3.COAGULOPATHY,HEMATOLOGICAL DISORDERS 4.CASEAREAN SECTION

Design outcomes

Primary

MeasureTime frame
TO DETERMINE THE EFFECTIVENESS OF UTEROTONIC (OXYTOCIN AND CARBETOCIN)WHICHHELPS IN REDUCING THE POSTPARTUM BLOOD LOSSTimepoint: 48 HRS AFTER THE DELIVERY BY COMPARING THE PRE HB AND POSTHB AND ESTIMATION OF BLOOD LOSS AFTER DELIVERY.—

Secondary

MeasureTime frame
TO ESTIMATE THE PROPORTION OF WOMEN RECEIVING EXTRAUTERTONIC DRUGS WOMEN REQUIRING TRANSFUSION OF BLOOD OR BLOOD PRODUCTS. EFFICACY OF THE DRUG IS MEASURED BY COMPARING THE BLOOD LOSS AND PREHB AND POST HB AFTER 48HRS AFTER DELIVERY FOR THE PREVENTION OF PPH SO THAT WE CAN DECREASE MATERNAL MORTALITY.Timepoint: COMPARING THE BLOOD LOSS AFTER THE THIRD STAGE OF LABOR AND 48HR AFTER THE DELIVERY COMPARING PRE HB AND POST HB—

Countries

India

Contacts

Public ContactDR VOORKARA UDAYSHREE

SDM COLLEGE MEDICAL SCIENCE AND HOSPITAL

drudayashree@yahoo.com9845960821

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026